Bone age and factors affecting skeletal maturation at diagnosis of paediatric Cushing's disease
- PMID: 20689994
- DOI: 10.1007/s11102-010-0246-3
Bone age and factors affecting skeletal maturation at diagnosis of paediatric Cushing's disease
Abstract
Paediatric Cushing's disease (CD) is usually associated with growth retardation, but there are only few published data on skeletal maturation at diagnosis. We analysed factors contributing to skeletal maturation and final height in Asian Indian patients with paediatric CD. We conducted retrospective analysis of 48 patients (29 males; 19 females) with mean age: 14.84 years at diagnosis (range 9-19 years). A single observer using the Greulich Pyle method determined the bone age (BA) of each child. BA delay, i.e. the difference between chronological age (CA) and BA, was compared with clinical and biochemical variables. BA delay was present in 35/48 (73%) patients (mean delay 1.6 years, range 0.5-5 years) and correlated negatively with height SDS (r = -0.594, P < 0.001) and positively with CA at diagnosis (r = 0.247, P < 0.05). There was no correlation with duration of symptoms before diagnosis, basal cortisol, midnight cortisol, ACTH or percentage suppression of low dose dexamethasone suppression cortisol (LDDST). We could not demonstrate any relationship between the duration of history before diagnosis and height SDS at final height. Mean final height SDS in patients was -1.84. We found that most children with CD had delayed BA and correlated significantly with CA and height SDS at diagnosis. Early diagnosis may reduce delay in skeletal maturation and thus contribute to optimal catch-up growth.
Similar articles
-
Factors influencing skeletal maturation at diagnosis of paediatric Cushing's disease.Horm Res. 2007;68(5):231-5. doi: 10.1159/000101336. Epub 2007 Mar 28. Horm Res. 2007. PMID: 17389813
-
Cushing's disease in childhood: presentation, investigation, treatment and long-term outcome.Horm Res. 2001;55 Suppl 1:24-30. doi: 10.1159/000063459. Horm Res. 2001. PMID: 11408758
-
Growth in disorders of adrenal hyperfunction.Horm Res. 2002;58 Suppl 1:39-43. doi: 10.1159/000064767. Horm Res. 2002. PMID: 12373013 Review.
-
The discriminatory value of the low-dose dexamethasone suppression test in the investigation of paediatric Cushing's syndrome.Horm Res. 2006;65(3):159-62. doi: 10.1159/000091830. Epub 2006 Mar 2. Horm Res. 2006. PMID: 16514243
-
MANAGEMENT OF ENDOCRINE DISEASE: Paediatric Cushing's disease.Eur J Endocrinol. 2015 Jul;173(1):R35-45. doi: 10.1530/EJE-15-0013. Eur J Endocrinol. 2015. PMID: 26036813 Review.
Cited by
-
Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 2, specific diseases.Nat Rev Endocrinol. 2024 May;20(5):290-309. doi: 10.1038/s41574-023-00949-7. Epub 2024 Feb 9. Nat Rev Endocrinol. 2024. PMID: 38336898 Review.
-
Evaluation of Bone Age in Children: A Mini-Review.Front Pediatr. 2021 Mar 12;9:580314. doi: 10.3389/fped.2021.580314. eCollection 2021. Front Pediatr. 2021. PMID: 33777857 Free PMC article. Review.
-
Continuum of glucose and bone metabolism impairment across autonomous cortisol secretion: A cross-sectional study.World J Diabetes. 2025 Mar 15;16(3):100580. doi: 10.4239/wjd.v16.i3.100580. World J Diabetes. 2025. PMID: 40093276 Free PMC article.
-
Paediatric Cushing's disease: Epidemiology, pathogenesis, clinical management and outcome.Rev Endocr Metab Disord. 2021 Dec;22(4):817-835. doi: 10.1007/s11154-021-09626-4. Epub 2021 Jan 30. Rev Endocr Metab Disord. 2021. PMID: 33515368 Free PMC article. Review.
-
Skeletal maturation in children with Cushing syndrome is not consistently delayed: the role of corticotropin, obesity, and steroid hormones, and the effect of surgical cure.J Pediatr. 2014 Apr;164(4):801-6. doi: 10.1016/j.jpeds.2013.11.065. Epub 2014 Jan 10. J Pediatr. 2014. PMID: 24412141 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources